Compare DexCom, Inc. (DXCM) vs Waste Management, Inc. (WM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs Waste Management, Inc. — how do they compare? DexCom, Inc. trades at $77.82 (market cap $28.06B), while Waste Management, Inc. trades at $240.47 (market cap $93.49B). The key difference: Waste Management, Inc. is far larger — about 3.3× DexCom, Inc.'s market cap, and Waste Management, Inc. pays a 1.52% dividend while DexCom, Inc. pays none. Which is the better fit depends on your goals.
| DXCM | WM | |
|---|---|---|
Market Cap | $28.06B | $93.49B |
Sector | Health | Industrials |
52-Week High | $89.53 | $246.51 |
52-Week Low | $54.84 | $196.77 |
Enterprise Value | $27.03B | $116.22B |
Dividend Yield | — | 1.52% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DexCom (DXCM) trades at $74.12, down 2.92% on the day, with a bullish technical signal from moving averages. The company demonstrates strong fundamentals with consistent revenue growth, expanding profit margins, and a track record of beating earnings estimates. Recent regulatory approvals for its G7 15-day CGM in Canada and pediatric clearance for its Stelo OTC system in the U.S. highlight ongoing product expansion.
The investment thesis centers on DexCom's leadership in the growing CGM market, supported by strong financial execution and analyst optimism. Key risks include competition from Abbott, the commercial unproven nature of expansion into non-insulin Type 2 diabetes patients, and potential disruption from GLP-1 drug adoption. The consensus price target of $84.33 suggests ~14% upside from current levels.
WM trades at $234.27, down 1.03% on the day, with strong technical momentum showing bullish moving averages and support at $231. The company demonstrates robust fundamentals with $25.2B revenue, 10.99% net margin, and consistent dividend payments. Recent earnings show mixed results with a Q1 2026 beat but Q3-Q4 2025 misses. Analysts maintain strong buy sentiment with a $264.17 consensus target, representing 12.8% upside potential from current levels.
WM presents a compelling investment case with stable cash flows, pricing power in waste management services, and renewable energy initiatives driving growth. Key risks include elevated debt levels (49.97% debt-to-asset ratio) and sensitivity to economic cycles. The stock's premium valuation (P/E 33.69) requires continued execution on margin expansion and revenue growth to justify current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About Waste Management, Inc.
Waste Management ranks as the largest integrated provider of traditional solid waste services in the United States, operating approximately 260 active landfills and about 340 transfer stations. The company serves residential, commercial, and industrial end markets and is also a leading recycler in North America.
Read more on WM →
